Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis

Kardiologia Polska

Volumn 65, Issue 9, 2007, Pages 1068-1075

  Flisiński, Mariusz ^a   Strózecki, Paweł ^a   Stefańska, Anna ^a   Zarzycka Lindner, Grazyna ^a   Brymora, Andrzej ^a   Manitius, Jacek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Chronic kidney disease; Haemodialysis; hsCRP; LVMI; Troponin I

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARDIAC TROPONIN I; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHORUS; TROPONIN I; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DEVEREUX FORMULA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEART MUSCLE INJURY; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOLOGY; MALE; MATHEMATICAL MODEL; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; REICHEK FORMULA; RISK FACTOR;

EID: 36048993915     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Manjunath G, Tighiouart H, Coresh J, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003; 63: 1121-9.
2. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-69.
3. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002; 137: 563-70.
4. Manske CL, Thomas W, Wang Y, et al. Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 1993; 44: 617-21.
5. Amann K, Breitbach M, Ritz E, et al. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998; 9: 1018-22.
6. Amann K, Ritz E. Microvascular disease - the Cinderella of uraemic heart disease. Nephrol Dial Transplant 2000; 15: 1493-503.
7. Aronow WS, Ahn C, Mercando AD, et al. Prevalence of coronary artery disease, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. Am J Cardiol 2000; 86: 1142-3, A9.
8. Khan IA, Wattanasuwan N, Mehta NJ, et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. J Am Coll Cardiol 2001; 38: 991-8.
9. Harnett JD, Foley RN, Kent GM, et al. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-90.
10. Del Carlo CH, O'Connor CM. Cardiac troponins in congestive hart failure. Am Heart J 1999; 138: 646-53.
11. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001; 59: 407-14.
12. Wang AY, Lam CW, Wang M, et al. Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients. Clin Chem 2007; 53: 882-9.
13. Wayand D, Baum H, Schätzle G, et al. Cardiac troponin T and I in end-stage renal failure. Clin Chem 2000; 46: 1345-50.
14. Vichairuangthum K, Leowattana W, Ong-Ajyooth L, et al. The relationship between serum concentration of cardiac troponin I in chronic renal failure patients and cardiovascular events. J Med Assoc Thai 2006; 89: 714-20.
15. Higgins JP, Higgins JA. Elevation of cardiac troponin I indicates more than myocardial ischemia. Clin Invest Med 2003; 26: 133-47.
16. Nakai K, Nakai K, Nagane Y, et al. Serum levels of cardiac troponin I and other marker proteins in patients with chronic renal failure. Clin Exp Nephrol 2004; 8: 43-7.
17. Ellis K, Dreisbach AW, Lertora JL. Plasma elimination of cardiac troponin I in end-stage renal disease. South Med J 2001; 94: 993-6.
18. Deléaval P, Descombes E, Magnin JL, et al. Differences in cardiac troponin I and T levels measured in asymptomatic hemodialysis patients with last generation immunoassays. Nephrol Ther 2006; 2: 75-81.
19. Neumayr G, Gaenzer H, Pfister R, et al. Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise. Am J Cardiol 2001; 87: 369-71, A10.
20. Rump LC, Amann K, Orth S, et al. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 2000; 15: 1735-8.
21. Abbas NA, John RI, Webb MC, et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem 2005; 51: 2059-66.
22. Lamb EJ, Kenny C, Abbas NA, et al. Cardiac troponin I concentration is commonly increased in nondialysis patients with CKD: experience with a sensitive assay. Am J Kidney Dis 2007; 49: 507-16.
23. Zumrutdal A, Demircan S, Seydaoglu G, et al. Atherosclerosis in haemodialysis patients without significant comorbidities: determinants of progression. Nephrology (Carlton) 2006; 11: 489-93.
24. Panichi V, Migliori M, De Pietro S, et al. C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron 2002; 91: 594-600.
25. Wong CK, Szeto CC, Chan MH, et al. Elevation of proinflammatory cytokines, C-reactive protein and cardiac troponin T in chronic renal failure patients on dialysis. Immunol Invest 2007; 36: 47-57.
26. Kanwar M, Hashem M, Rosman H, et al. Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients. Am J Cardiol 2006; 98: 1283-7.
27. Apple FS, Murakami MM, Pearce LA, et al. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004; 50: 2279-85.
28. Park CW, Shin YS, Kim CM, et al. Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis 2002; 40: 1230-9.
29. Uehara K, Nomura M, Ozaki Y, et al. High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction. Heart Vessels 2003; 18: 67-74.
30. Kim BS, Jeon DS, Shin MJ, et al. Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis. Am J Nephrol 2005; 25: 189-95.
31. Levin A. Anemia and left ventricular hypertrophy in chronic kidney disease populations: A review of the current state of knowledge. Kidney Int Suppl 2002; 80: S35-8.
32. Wrenn K, Blair R, Parl FF, et al. Calcium-phosphorus product and troponin-T values in renal failure. Am J Emerg Med 2006; 24; 836-8.
33. Alcalai R, Planer D, Culhaoglu A, et al. Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. Arch Intern Med 2007; 167: 276-8.
34. Gulati J, Akella AB, Nikolic SD, et al. Shifts in contractile regulatory protein subunits troponin T and troponin I in cardiac hypertrophy. Biochem Biophys Res Commun 1994; 202: 384-90.
35. Ricchiuti V, Zhang J, Apple FS. Cardiac troponin I and T alterations in hearts with severe left ventricular remodeling. Clin Chem 1997; 43: 990-5.
36. Sharma R, Gaze DC, Pellerin D, et al. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart 2006; 92: 804-9.
37. Bueti J, Krahn J, Karpinski M, et al. Troponin I testing in dialysis patients presenting to the emergency room: does troponin I predict the 30-day outcome? Nephron Clin Pract 2006; 103: c129-36.
38. Flores LM, Hernández Dominguez JL, Otero A, et al. Cardiac troponin I determination in patients with chronic renal failure. Nefrologia 2006; 26: 107-12.